XML 31 R22.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Options Outstanding

Information with respect to options outstanding is summarized as follows (in dollars):

 

       Weighted   Aggregate 
   Number of   Average   Intrinsic 
   Options   Exercise Price   Value 
Outstanding as of December 31, 2022   1,031,000   $1.00   $3,609 
Granted   -    -      
Exercised   -    -      
Cancelled   (225,000)   1.00      
Outstanding as of September 30, 2023   806,000   $1.00   $6,165 
Vested and exercisable as of September 30, 2023   683,341   $1.00   $4,086 
Vested and expected to vest at September 30, 2023   806,000   $1.00   $6,165 
Schedule of Fair Value of Stock Options

 

   September 30,   December 31, 
   2023   2022 
Risk-free interest rate   0.00%   0.73% - 2.96%  
Expected dividend yield   -    - 
Expected term in years   -    1.36 - 1.85 
Expected volatility   0.00%   50.0% - 86.3%  
Schedule of Restricted Stock Award Activity

 

       Weighted 
   Number of   Average Grant 
   Awards   Date Fair Value 
Nonvested at December 31, 2021   -   $- 
Granted   400,000    1.48 
Vested   (200,000)   1.48 
Nonvested at December 31, 2022   200,000   $1.48 
Granted   100,000    7.21 
Vested   (300,000)   3.39 
Nonvested at September 30, 2023   -   $- 
Schedule of Stock-based Compensation Expense

The Company recorded stock-based compensation expense in the following categories on the accompanying consolidated statements of operations for the periods presented (in thousands):

 

   2023   2022   2023   2022 
   Three Months Ended September 30,   Nine Months Ended September 30, 
   2023   2022   2023   2022 
Research and development  $16   $261   $432   $377 
General and administrative   782    90    1,014    1,109 
Total stock-based compensation expense  $798   $351   $1,446   $1,486